Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

Trial Profile

Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs KTP-001 (Primary)
  • Indications Intervertebral disc displacement
  • Focus Adverse reactions
  • Sponsors Teijin
  • Most Recent Events

    • 29 Nov 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2018.
    • 29 Nov 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 May 2014 Planned number of patients changed from 32 to 24 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top